Skip to main navigation Skip to search Skip to main content

Management of Dyslipidemia in Endocrine Diseases

  • Lisa R. Tannock

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations
Original languageEnglish
Pages (from-to)589-602
Number of pages14
JournalEndocrinology and Metabolism Clinics of North America
Volume51
Issue number3
DOIs
StatePublished - Sep 2022

Bibliographical note

Funding Information:
This work was supported in part by funding from the National Institutes of Health R01 HL147381 and the Department of Veterans Affairs BX004275 .

Funding

This work was supported in part by funding from the National Institutes of Health R01 HL147381 and the Department of Veterans Affairs BX004275 .

FundersFunder number
National Institutes of Health (NIH)
U.S. Department of Veterans AffairsI01BX004275, BX004275
National Heart, Lung, and Blood Institute (NHLBI)R01HL147381

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Cardiovascular
    • Dyslipidemia
    • Endocrine
    • Lipids

    ASJC Scopus subject areas

    • Endocrinology, Diabetes and Metabolism
    • Endocrinology

    Fingerprint

    Dive into the research topics of 'Management of Dyslipidemia in Endocrine Diseases'. Together they form a unique fingerprint.

    Cite this